Harmony Biosciences Holdings (HRMY) Deferred Taxes (2022 - 2026)
Harmony Biosciences Holdings recorded quarterly Deferred Taxes of -$3.9 million in Q1 2026, down 152.37% quarter-over-quarter from $7.4 million in Q4 2025, and up 10.39% year-over-year from -$3.5 million in Q1 2025.
Harmony Biosciences Holdings' Deferred Taxes history runs 5 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 10.39% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$6.9 million (up 77.26% YoY), while the FY2025 annual figure was -$7.3 million, up 75.08% from the prior year.
- Deferred Taxes came in at -$3.9 million for Q1 2026 at Harmony Biosciences Holdings, down from $7.4 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $7.4 million in Q4 2025 to a low of -$14.3 million in Q2 2024.
- A 5-year average of -$4.2 million and a median of -$4.2 million in 2022 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes slumped 697.68% in 2024 and jumped 209.89% in 2025, its largest moves.
- Harmony Biosciences Holdings' Deferred Taxes stood at -$4.3 million in 2022, then jumped by 126.34% to $1.1 million in 2023, then plunged by 697.68% to -$6.7 million in 2024, then surged by 209.89% to $7.4 million in 2025, then sank by 152.37% to -$3.9 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$3.9 million, $7.4 million, and -$3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | -3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.86 Mn |
| Dec 31, 2025 | 7.38 Mn |
| Sep 30, 2025 | -3.88 Mn |
| Jun 30, 2025 | -6.49 Mn |
| Mar 31, 2025 | -4.31 Mn |
| Dec 31, 2024 | -6.71 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -14.28 Mn |
| Mar 31, 2024 | -3.48 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | -6.91 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -3.44 Mn |
| Dec 31, 2022 | -4.26 Mn |